Federated Hermes Inc. Has $45.43 Million Holdings in Maximus, Inc. (NYSE:MMS)

Federated Hermes Inc. trimmed its position in Maximus, Inc. (NYSE:MMS) by 3.0% in the second quarter, HoldingsChannel.com reports. The firm owned 530,117 shares of the health services provider’s stock after selling 16,198 shares during the period. Federated Hermes Inc.’s holdings in Maximus were worth $45,431,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MMS. Rise Advisors LLC raised its stake in shares of Maximus by 1,445.0% in the 1st quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock valued at $26,000 after buying an additional 289 shares in the last quarter. GAMMA Investing LLC increased its stake in Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 238 shares during the period. Blue Trust Inc. increased its stake in Maximus by 201.5% in the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 262 shares during the period. Kapitalo Investimentos Ltda acquired a new position in Maximus in the fourth quarter worth about $52,000. Finally, Archer Investment Corp lifted its stake in Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares during the period. 97.21% of the stock is owned by institutional investors.

Maximus Trading Up 2.4 %

MMS stock opened at $88.70 on Friday. Maximus, Inc. has a 1-year low of $72.39 and a 1-year high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The business’s 50 day moving average is $89.47 and its 200-day moving average is $85.97. The firm has a market cap of $5.34 billion, a P/E ratio of 23.28 and a beta of 0.76.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The business’s revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.78 earnings per share. Equities analysts anticipate that Maximus, Inc. will post 6.12 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Investors of record on Thursday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.35%. The ex-dividend date was Thursday, August 15th. Maximus’s dividend payout ratio is currently 31.50%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.